Idrees, M.; Xu, L.; El Sheikh, M.; Sidrat, T.; Song, S.-H.; Joo, M.-D.; Lee, K.-L.; Kong, I.-K.
The PPARδ Agonist GW501516 Improves Lipolytic/Lipogenic Balance through CPT1 and PEPCK during the Development of Pre-Implantation Bovine Embryos. Int. J. Mol. Sci. 2019, 20, 6066.
https://doi.org/10.3390/ijms20236066
AMA Style
Idrees M, Xu L, El Sheikh M, Sidrat T, Song S-H, Joo M-D, Lee K-L, Kong I-K.
The PPARδ Agonist GW501516 Improves Lipolytic/Lipogenic Balance through CPT1 and PEPCK during the Development of Pre-Implantation Bovine Embryos. International Journal of Molecular Sciences. 2019; 20(23):6066.
https://doi.org/10.3390/ijms20236066
Chicago/Turabian Style
Idrees, Muhammad, Lianguang Xu, Marwa El Sheikh, Tabinda Sidrat, Seok-Hwan Song, Myeong-Don Joo, Kyeong-Lim Lee, and Il-Keun Kong.
2019. "The PPARδ Agonist GW501516 Improves Lipolytic/Lipogenic Balance through CPT1 and PEPCK during the Development of Pre-Implantation Bovine Embryos" International Journal of Molecular Sciences 20, no. 23: 6066.
https://doi.org/10.3390/ijms20236066
APA Style
Idrees, M., Xu, L., El Sheikh, M., Sidrat, T., Song, S. -H., Joo, M. -D., Lee, K. -L., & Kong, I. -K.
(2019). The PPARδ Agonist GW501516 Improves Lipolytic/Lipogenic Balance through CPT1 and PEPCK during the Development of Pre-Implantation Bovine Embryos. International Journal of Molecular Sciences, 20(23), 6066.
https://doi.org/10.3390/ijms20236066